Floatz logo

Therapeutic Asset Ratings

184 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Emicizumab
Hemophilia A
Emory UniversityP4BBB (77)
Letrozole
Invasive Breast Carcinoma
Emory UniversityP4BBB (74)
Activated Prothrombin Complex Concentrate
Hemophilia A
Emory UniversityP4BBB (72)
Rfviia
Hemophilia A
Emory UniversityP4BBB (72)
CIS-DIAMMINEDICHLOROPLATINUM II
Unspecified Adult Solid Tumor, Protocol Specific
Emory UniversityP3BB (70)
Nivolumab
Adenocarcinoma of the Lung
Emory UniversityP3BB (70)
PANITUMUMAB
RAS Wild Type
Emory UniversityP3BB (66)
DEXKETOPROFEN
Pregnancy Related
Emory UniversityP4BB (65)
ELEXACAFTOR
Non-cystic Fibrosis Bronchiectasis
Emory UniversityP4BB (65)
Ivacaftor
Non-cystic Fibrosis Bronchiectasis
Emory UniversityP4BB (65)
METAMIZOLE
Pregnancy Related
Emory UniversityP4BB (65)
Naltrexone
HIV Infections
Emory UniversityP4BB (65)
NEPENTHE
Cesarean Delivery
Emory UniversityP4BB (65)
Tezacaftor
Non-cystic Fibrosis Bronchiectasis
Emory UniversityP4BB (65)
Ipilimumab
Triple-Negative Breast Carcinoma
Emory UniversityP2BB (65)
Dfn-15
Advanced Hepatocellular Carcinoma
Emory UniversityP4BB (64)
Naltrexone
Chronic Neuropathic Pain
Emory UniversityP4BB (64)
Acalabrutinib
Indolent B-Cell Non-Hodgkin Lymphoma
Emory UniversityP2BB (64)
SIMVASTATIN
Invasive Breast Carcinoma
Emory UniversityP2BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoproliferative Disorder
Emory UniversityP2B (63)
Obinutuzumab
Lymphoplasmacytic Lymphoma
Emory UniversityP2B (63)
Montelukast
Multiple Myeloma
Emory UniversityP4B (62)
Spironolactone
Mild Cognitive Impairment
Emory UniversityP4B (62)
Evomela
Sickle Cell Disease
Emory UniversityP3B (62)
(+)-VINCRISTINE
Lymphoplasmacytic Lymphoma
Emory UniversityP3B (62)
Showing 1 to 25 of 184 assets
PreviousPage 1 of 8Next